TerminatedNCT05159830
Cannabidiol for Reducing Drinking in Addiction
Medication studyAges 18–65France
Understand this study
Who could participate?
Listed age limits: 18 years to 65 years.
- Listed locations
- BronSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: October 25, 2024
- Recruitment status
- Terminated
- Enrollment listed in the registry
- 10
- Sponsor
- Hôpital le Vinatier
- Sponsor type
- Hospital / academic medical center
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- France
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT05159830
- Official title
Show the full official title
Cannabidiol for Reducing Drinking in Alcohol Use Disorder and Modifying the Effects of Alcohol on the Brain and the Liver: a Phase 2 Clinical Trial.-The CARAMEL Study
Recruitment & locations
TerminatedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Bron
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Hôpital le Vinatier, a hospital or academic medical center.
Does this study involve medication?
Yes. The study involves medication, including Cannabidiol oral oil and Placebo oral oil.
Who can participate?
Listed age limits: 18 years to 65 years.
Is this study still recruiting?
The registry lists this study as terminated.
